投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
3.9 %
年文章数
1710
作者需知
暂无数据
NCBI查询
期刊简介
稿件收录要求
稿件收录要求
Published by International Medical Press.
ISSN: 1359-6535.
The field of antiviral therapy is expanding at an unprecedented rate. The tremendous expansion in drug screening and rational drug design brought about by the HIV pandemic, together with gathering interest in new viral targets' such as the hepatitis and papillomaviruses, means that more antiviral agents than ever are reaching clinical trials. Several journals now deal exclusively with the chemistry, design and pre-clinical development of antiviral agents. Previously, however, publications concerning clinical aspects of antiviral therapy have been dispersed among a wide range of different journals, making it increasingly difficult to keep abreast of this multidisciplinary field. Antiviral Therapy is the first international journal solely devoted to the clinical development and use of antiviral agents. It publishes original scientific papers in all therapeutic areas, including: results of clinical studies in all phases; viral diagnostics and individualization of antiviral therapy; study design issues in the clinical assessment of antivirals; antiviral drug safety and safety monitoring; mechanisms of resistance to antiviral agents; pharmacoepidemiology of viral diseases. Antiviral Therapy also features review articles, editorials, book reviews and a letters section to provide a forum for discussion. Antiviral Therapy is an official publication of the International Society for Antiviral Research
The field of antiviral therapy is expanding at an unprecedented rate. The tremendous expansion in drug screening and rational drug design brought about by the HIV pandemic, together with gathering interest in new viral targets' such as the hepatitis and papillomaviruses, means that more antiviral agents than ever are reaching clinical trials. Several journals now deal exclusively with the chemistry, design and pre-clinical development of antiviral agents. Previously, however, publications concerning clinical aspects of antiviral therapy have been dispersed among a wide range of different journals, making it increasingly difficult to keep abreast of this multidisciplinary field. Antiviral Therapy is the first international journal solely devoted to the clinical development and use of antiviral agents. It publishes original scientific papers in all therapeutic areas, including: results of clinical studies in all phases; viral diagnostics and individualization of antiviral therapy; study design issues in the clinical assessment of antivirals; antiviral drug safety and safety monitoring; mechanisms of resistance to antiviral agents; pharmacoepidemiology of viral diseases. Antiviral Therapy also features review articles, editorials, book reviews and a letters section to provide a forum for discussion. Antiviral Therapy is an official publication of the International Society for Antiviral Research
